Skip to main content

Advertisement

Log in

Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in children

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Background

Though the pathology of optic pathway tumor is mostly pilocytic astrocytoma, the benign tumor behaves like malignant tumor because total resection is not feasible. Adjuvant chemotherapy might be a reasonable strategy for management of these low grade tumors which keep growing. We evaluate the responsiveness of optic pathway tumor to cisplatin-based chemotherapy.

Methods

Patients with unresectable and progressive optic pathway tumors received conventional chemotherapy including cisplatin, etoposide, and vinblastine were enrolled in this study from 1992 to 2007. Patients treated with radiotherapy previously were excluded. Brain MRI was performed every 3 months to evaluate the objective response to chemotherapy.

Results

There are seven girls and nine boys enrolled in this study. The median age at diagnosis was 30 months old (range from 3 months to 11 years old). The median follow-up duration was 81.5 months (range from 24 months to 14.5 years). The pathology showed pilocytic astrocytomas in 11 patients, astrocytoma in one patient, and anaplastic astrocytomas in two patients. The 6-month progression-free survival (PFS) is 100%, 12-month PFS is 81.3%, 3-year PFS is 71.4% and 5-year PFS is 55.5% respectively. The toxicity of the cisplatin-based chemotherapy showed mild bone marrow suppression in 13 patients (81.3%), infection in nine patients (56.3%), gastrointestinal discomfort in seven patients (43.8%), renal insufficiency in two patient (12.5%), cerebral salt wasting syndrome with hyponatremia in one patient (6.25%) and high pitch hearing loss in two patients (12.5%).

Conclusion

Cisplatin-based chemotherapy is an effective regimen for control of progressive optic pathway tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Alvord EC Jr, Lofton S (1988) Gliomas of the optic nerve or chiasm. Outcome by patients’ age, tumor site, and treatment. J Neurosurg 68:85–98

    PubMed  Google Scholar 

  2. Beyer RA, Paden P, Sobel DF, Flynn FG (1986) Moyamoya pattern of vascular occlusion after radiotherapy for glioma of the optic chiasm. Neurology 36:1173–1178

    PubMed  CAS  Google Scholar 

  3. Cohen BH, Rothner AD (1989) Incidence, types, and management of cancer in patients with neurofibromatosis. Oncology (Williston Park) 3:23–30

    CAS  Google Scholar 

  4. Cohen ME, Duffner PK (1991) Optic pathway tumors. Neurol Clin 9:467–477

    PubMed  CAS  Google Scholar 

  5. Deliganis AV, Geyer JR, Berger MS (1996) Prognostic significance of type 1 neurofibromatosis (von Recklinghausen Disease) in childhood optic glioma. Neurosurgery 38:1114–1118

    Article  PubMed  CAS  Google Scholar 

  6. Dosoretz DE, Blitzer PH, Wang CC, Linggood RM (1980) Management of glioma of the optic nerve and/or chiasm: an analysis of 20 cases. Cancer 45:1467–1471

    Article  PubMed  CAS  Google Scholar 

  7. Dutton JJ (1994) Gliomas of the anterior visual pathway. Surv Ophthalmol 38:427–452

    Article  PubMed  CAS  Google Scholar 

  8. Dutton JJ (1991) Optic nerve gliomas and meningiomas. Neurol Clin 9:163–177

    PubMed  CAS  Google Scholar 

  9. Fisher BJ, Leighton CC, Vujovic O, Macdonald DR, Stitt L (2001) Results of a policy of surveillance alone after surgical management of pediatric low grade gliomas. Int J Radiat Oncol Biol Phys 51:704–710

    PubMed  CAS  Google Scholar 

  10. Grill J, Couanet D, Cappelli C, Habrand JL, Rodriguez D, Sainte-Rose C, Kalifa C (1999) Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 45:393–396

    Article  PubMed  CAS  Google Scholar 

  11. Hoffman HJ, Humphreys RP, Drake JM, Rutka JT, Becker LE, Jenkin D, Greenberg M (1993) Optic pathway/hypothalamic gliomas: a dilemma in management. Pediatr Neurosurg 19:186–195

    Article  PubMed  CAS  Google Scholar 

  12. Horwich A, Bloom HJ (1985) Optic gliomas: radiation therapy and prognosis. Int J Radiat Oncol Biol Phys 11:1067–1079

    PubMed  CAS  Google Scholar 

  13. Housepian EM, Chi TL (1993) Neurofibromatosis and optic pathways gliomas. J Neurooncol 15:51–55

    Article  PubMed  CAS  Google Scholar 

  14. Hoyt WF, Baghdassarian SA (1969) Optic glioma of childhood. Natural history and rationale for conservative management. Br J Ophthalmol 53:793–798

    Article  PubMed  CAS  Google Scholar 

  15. Imes RK, Hoyt WF (1986) Childhood chiasmal gliomas: update on the fate of patients in the 1969 San Francisco Study. Br J Ophthalmol 70:179–182

    Article  PubMed  CAS  Google Scholar 

  16. Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, Goldwein JW, Sutton LN, Radcliffe J, Molloy PT (1995) Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 75:1051–1059

    Article  PubMed  CAS  Google Scholar 

  17. Jenkin D, Angyalfi S, Becker L, Berry M, Buncic R, Chan H, Doherty M, Drake J, Greenberg M, Hendrick B (1993) Optic glioma in children: surveillance, resection, or irradiation? Int J Radiat Oncol Biol Phys 25:215–225

    PubMed  CAS  Google Scholar 

  18. Kestle JR, Hoffman HJ, Mock AR (1993) Moyamoya phenomenon after radiation for optic glioma. J Neurosurg 79:32–35

    PubMed  CAS  Google Scholar 

  19. Korones DN, Padowski J, Factor BA, Constine LS (2003) Do children with optic pathway tumors have an increased frequency of other central nervous system tumors? Neuro Oncol 5:116–120

    Article  PubMed  Google Scholar 

  20. Kuo DJ, Weiner HL, Wisoff J, Miller DC, Knopp EA, Finlay JL (2003) Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas. J Pediatr Hematol Oncol 25:372–378

    Article  PubMed  Google Scholar 

  21. Kwon Y, Bae JS, Kim JM, Lee DH, Kim SY, Ahn JS, Kim JH, Kim CJ, Kwun BD, Lee JK (2005) Visual changes after gamma knife surgery for optic nerve tumors. Report of three cases. J Neurosurg 102(Suppl):143–146

    PubMed  Google Scholar 

  22. Laithier V, Grill J, Le Deley MC, Ruchoux MM, Couanet D, Doz F, Pichon F, Rubie H, Frappaz D, Vannier JP, Babin-Boilletot A, Sariban E, Chastagner P, Zerah M, Raquin MA, Hartmann O, Kalifa C (2003) Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy–results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol 21:4572–4578

    Article  PubMed  CAS  Google Scholar 

  23. Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 41:143–149

    Article  PubMed  CAS  Google Scholar 

  24. Mahoney DH Jr., Cohen ME, Friedman HS, Kepner JL, Gemer L, Langston JW, James HE, Duffner PK, Kun LE (2000) Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. Neuro Oncol 2:213–220

    Article  PubMed  Google Scholar 

  25. Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, Riva D, Ruggiero A, Valentini L, Mazza E, Genitori L, Di RC, Navarria P, Casanova M, Ferrari A, Luksch R, Terenziani M, Balestrini MR, Colosimo C, Fossati-Bellani F (2002) High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol 20:4209–4216

    Article  PubMed  CAS  Google Scholar 

  26. Oxenhandler DC, Sayers MP (1978) The dilemma of childhood optic gliomas. J Neurosurg 48:34–41

    Article  PubMed  CAS  Google Scholar 

  27. Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, Prados M, Jakacki R, Reaman G, Needles MN (1993) Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11:850–856

    PubMed  CAS  Google Scholar 

  28. Sayli T, Cemeroglu AP, Tuncer AM, Gurgey A (1993) Acute lymphoblastic leukemia following optic glioma treated by radiotherapy and surgery. Acta Paediatr 82:327–328

    Article  PubMed  CAS  Google Scholar 

  29. Shuper A, Horev G, Kornreich L, Michowiz S, Weitz R, Zaizov R, Cohen IJ (1997) Visual pathway glioma: an erratic tumour with therapeutic dilemmas. Arch Dis Child 76:259–263

    PubMed  CAS  Google Scholar 

  30. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van GM, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for research and treatment of cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216

    Article  PubMed  CAS  Google Scholar 

  31. Tow SL, Chandela S, Miller NR, Avellino AM (2003) Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 28:262–270

    Article  PubMed  Google Scholar 

  32. Tym R (1961) Piloid gliomas of the anterior optic pathways. Br J Surg 49:322–331

    Article  PubMed  CAS  Google Scholar 

  33. Wisoff JH, Abbott R, Epstein F (1990) Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 73:661–667

    PubMed  CAS  Google Scholar 

  34. Wong TT, Ho DM, Chang KP, Yen SH, Guo WY, Chang FC, Liang ML, Pan HC, Chung WY (2005) Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975–2004). Cancer 104:2156–2167

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kai-Ping Chang.

Additional information

Ting-Rong Hsu and Kai-Ping Chang contributed equally to this paper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hsu, TR., Wong, TT., Chang, FC. et al. Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in children. Childs Nerv Syst 24, 1457–1461 (2008). https://doi.org/10.1007/s00381-008-0707-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-008-0707-4

Keywords

Navigation